These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Activation of lateral hypothalamic mGlu1 and mGlu5 receptors elicits feeding in rats. Charles JR, Duva MA, Ramirez GJ, Lara RL, Yang CR, Stanley BG. Neuropharmacology; 2014 Apr; 79():59-65. PubMed ID: 24219858 [Abstract] [Full Text] [Related]
23. Activation of mGlu1 but not mGlu5 metabotropic glutamate receptors contributes to postischemic neuronal injury in vitro and in vivo. Meli E, Picca R, Attucci S, Cozzi A, Peruginelli F, Moroni F, Pellegrini-Giampietro DE. Pharmacol Biochem Behav; 2002 Sep; 73(2):439-46. PubMed ID: 12117599 [Abstract] [Full Text] [Related]
24. Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective. Bruno V, Ksiazek I, Battaglia G, Lukic S, Leonhardt T, Sauer D, Gasparini F, Kuhn R, Nicoletti F, Flor PJ. Neuropharmacology; 2000 Sep; 39(12):2223-30. PubMed ID: 10974306 [Abstract] [Full Text] [Related]
25. mGluR5, but not mGluR1, antagonist modifies MK-801-induced locomotor activity and deficit of prepulse inhibition. Pietraszek M, Gravius A, Schäfer D, Weil T, Trifanova D, Danysz W. Neuropharmacology; 2005 Jul; 49(1):73-85. PubMed ID: 15992582 [Abstract] [Full Text] [Related]
26. Permissive role of adenosine A2A receptors on metabotropic glutamate receptor 5 (mGluR5)-mediated effects in the striatum. Domenici MR, Pepponi R, Martire A, Tebano MT, Potenza RL, Popoli P. J Neurochem; 2004 Sep; 90(5):1276-9. PubMed ID: 15312183 [Abstract] [Full Text] [Related]
27. Metabotropic glutamate autoreceptors of the mGlu(5) subtype positively modulate neuronal glutamate release in the rat forebrain in vitro. Thomas LS, Jane DE, Harris JR, Croucher MJ. Neuropharmacology; 2000 Jul 10; 39(9):1554-66. PubMed ID: 10854900 [Abstract] [Full Text] [Related]
28. Characterisation of the actions of group I metabotropic glutamate receptor subtype selective ligands on excitatory amino acid release and sodium-dependent re-uptake in rat cerebrocortical minislices. Fazal A, Parker F, Palmer AM, Croucher MJ. J Neurochem; 2003 Sep 10; 86(6):1346-58. PubMed ID: 12950444 [Abstract] [Full Text] [Related]
29. Neuroprotective activity of N-acetylaspartylglutamate in cultured cortical cells. Bruno V, Wroblewska B, Wroblewski JT, Fiore L, Nicoletti F. Neuroscience; 1998 Aug 10; 85(3):751-7. PubMed ID: 9639269 [Abstract] [Full Text] [Related]
30. Adenosine A2A receptors and metabotropic glutamate 5 receptors are co-localized and functionally interact in the hippocampus: a possible key mechanism in the modulation of N-methyl-D-aspartate effects. Tebano MT, Martire A, Rebola N, Pepponi R, Domenici MR, Grò MC, Schwarzschild MA, Chen JF, Cunha RA, Popoli P. J Neurochem; 2005 Nov 10; 95(4):1188-200. PubMed ID: 16271052 [Abstract] [Full Text] [Related]
31. The excitoprotective effect of N-methyl-D-aspartate receptors is mediated by a brain-derived neurotrophic factor autocrine loop in cultured hippocampal neurons. Jiang X, Tian F, Mearow K, Okagaki P, Lipsky RH, Marini AM. J Neurochem; 2005 Aug 10; 94(3):713-22. PubMed ID: 16000165 [Abstract] [Full Text] [Related]
32. Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo. Vernon AC, Zbarsky V, Datla KP, Croucher MJ, Dexter DT. J Neurochem; 2007 Nov 10; 103(3):1075-91. PubMed ID: 17714448 [Abstract] [Full Text] [Related]
33. Changes in rat serum corticosterone after treatment with metabotropic glutamate receptor agonists or antagonists. Johnson MP, Kelly G, Chamberlain M. J Neuroendocrinol; 2001 Aug 10; 13(8):670-7. PubMed ID: 11489083 [Abstract] [Full Text] [Related]
34. Metabotropic glutamate receptor 5 activation enhances tyrosine phosphorylation of the N-methyl-D-aspartate (NMDA) receptor and NMDA-induced cell death in hippocampal cultured neurons. Takagi N, Besshoh S, Marunouchi T, Takeo S, Tanonaka K. Biol Pharm Bull; 2012 Aug 10; 35(12):2224-9. PubMed ID: 23207774 [Abstract] [Full Text] [Related]
35. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice. Kozela E, Pilc A, Popik P. Psychopharmacology (Berl); 2003 Jan 10; 165(3):245-51. PubMed ID: 12442203 [Abstract] [Full Text] [Related]
37. Co-localization and functional interaction between adenosine A(2A) and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum. Rodrigues RJ, Alfaro TM, Rebola N, Oliveira CR, Cunha RA. J Neurochem; 2005 Feb 01; 92(3):433-41. PubMed ID: 15659214 [Abstract] [Full Text] [Related]
38. The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats. Koltunowska D, Gibula-Bruzda E, Kotlinska JH. Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug 01; 45():242-9. PubMed ID: 23623810 [Abstract] [Full Text] [Related]
39. Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease. Armentero MT, Fancellu R, Nappi G, Bramanti P, Blandini F. Neurobiol Dis; 2006 Apr 01; 22(1):1-9. PubMed ID: 16289868 [Abstract] [Full Text] [Related]
40. Neuroprotective effects of MTEP, a selective mGluR5 antagonists and neuropeptide Y on the kainate-induced toxicity in primary neuronal cultures. Domin H, Kajta M, Smiałowska M. Pharmacol Rep; 2006 Apr 01; 58(6):846-58. PubMed ID: 17220542 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]